Australia's largest stock trading and investment forum Australia's #1 stock forum

KZA

0.00%

8.0¢ kazia therapeutics limited

Gil Mor, page-27

First 27 Last

Share
Profile

Follow
Ninja_Chook

1,347 Posts.

17

24/08/15

11:19

Post #: 15861364
Share

Originally posted by qqqqqqqqq ↑

IMO, the $33m that can potentially be raised from the 30c December 2015 options is crucial going forward as pre trial pre requisites and clinical trial phases going forward are very costly and lengthy procedures and the $40m plus cash at present will fall well short of what will be required over the next few years of human trials

The path is to develop drugs to work with chemotherapy to fight cancer or develop new drugs . It will always come down to toxicity as hundreds of patients will need to be monitored over many years

Then there is non oncology which is much more expensive

Eli Lilly latest trial on Alzheimer's.

''It's a high risk, high reward bet by Eli Lilly. Phase III trials are expensive, costing north of $100 million by themselves. Arfaei said he wouldn't be surprised if the overall cost of development for this program is more than $1 billion from beginning to potential approval. ''

http://money.cnn.com/2015/07/21/investing/alzheimers-eli-lilly-drugs/

DYOR

Expand

All very true Q. Which is why it is important to note what the Acting CEO, Iain Ross, said in his first, and last, announcement, "Whilst we do not rule out securing third party collaborations and partnerships to further validate and fund our programs."

Novogen has now flagged that they are open to deals with other parties.

NRT Price at posting: 15.0¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

The winners & losers on market if negative gearing were gone

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

There are more pages in this discussion • 5 more messages in this thread...

First 27 Last

Add KZA (ASX) to my watchlist

Gil Mor, page-27

Top Stories

The winners & losers on market if negative gearing were gone

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACCC seeks Olam divestments before it can buy Namoi Cotton

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News